share_log

19,565 Shares in Phreesia, Inc. (NYSE:PHR) Purchased by M Holdings Securities Inc.

Defense World ·  Sep 17, 2022 04:21

M Holdings Securities Inc. acquired a new position in shares of Phreesia, Inc. (NYSE:PHR – Get Rating) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 19,565 shares of the company's stock, valued at approximately $516,000.

Several other large investors have also made changes to their positions in the business. Advisor Group Holdings Inc. raised its holdings in Phreesia by 63.4% in the 4th quarter. Advisor Group Holdings Inc. now owns 1,319 shares of the company's stock valued at $55,000 after acquiring an additional 512 shares in the last quarter. Edmond DE Rothschild Holding S.A. raised its holdings in Phreesia by 2.2% in the 1st quarter. Edmond DE Rothschild Holding S.A. now owns 37,650 shares of the company's stock valued at $992,000 after acquiring an additional 800 shares in the last quarter. Select Equity Group L.P. raised its holdings in Phreesia by 3.6% in the 4th quarter. Select Equity Group L.P. now owns 29,057 shares of the company's stock valued at $1,211,000 after acquiring an additional 998 shares in the last quarter. Envestnet Asset Management Inc. raised its holdings in Phreesia by 11.7% in the 1st quarter. Envestnet Asset Management Inc. now owns 9,692 shares of the company's stock valued at $255,000 after acquiring an additional 1,015 shares in the last quarter. Finally, Raymond James Financial Services Advisors Inc. raised its holdings in Phreesia by 20.7% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 8,427 shares of the company's stock valued at $222,000 after acquiring an additional 1,447 shares in the last quarter. Institutional investors and hedge funds own 89.39% of the company's stock.

Get Phreesia alerts:

Phreesia Stock Down 3.6 %

Shares of PHR opened at $27.70 on Friday. The firm has a market capitalization of $1.46 billion, a price-to-earnings ratio of -7.94 and a beta of 0.75. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.40 and a current ratio of 4.40. The business's fifty day moving average price is $24.66 and its two-hundred day moving average price is $24.10. Phreesia, Inc. has a 52 week low of $13.19 and a 52 week high of $76.10.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the company. JMP Securities cut their price target on Phreesia from $50.00 to $34.00 and set a "market outperform" rating for the company in a report on Friday, June 3rd. Canaccord Genuity Group lowered their price objective on Phreesia from $37.00 to $36.00 and set a "buy" rating on the stock in a research note on Thursday, September 8th. SVB Leerink upped their price objective on Phreesia from $27.00 to $31.00 and gave the company a "market perform" rating in a research note on Thursday, September 8th. KeyCorp initiated coverage on Phreesia in a research note on Thursday. They issued an "overweight" rating and a $40.00 price objective on the stock. Finally, Guggenheim upped their price objective on Phreesia from $30.00 to $35.00 and gave the company a "buy" rating in a research note on Thursday, September 8th. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat.com, Phreesia has an average rating of "Moderate Buy" and a consensus price target of $36.21.

Insider Buying and Selling at Phreesia

In other Phreesia news, Director Gillian Munson sold 2,605 shares of the stock in a transaction on Monday, July 11th. The stock was sold at an average price of $25.59, for a total value of $66,661.95. Following the transaction, the director now directly owns 21,550 shares in the company, valued at approximately $551,464.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, SVP Michael J. Davidoff sold 5,046 shares of the stock in a transaction on Friday, June 24th. The stock was sold at an average price of $25.11, for a total value of $126,705.06. Following the transaction, the senior vice president now owns 110,509 shares of the company's stock, valued at approximately $2,774,880.99. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Gillian Munson sold 2,605 shares of the stock in a transaction on Monday, July 11th. The shares were sold at an average price of $25.59, for a total value of $66,661.95. Following the completion of the transaction, the director now directly owns 21,550 shares in the company, valued at approximately $551,464.50. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 9,055 shares of company stock worth $228,467. Insiders own 5.50% of the company's stock.

Phreesia Company Profile

(Get Rating)

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments.

Featured Articles

  • Get a free copy of the StockNews.com research report on Phreesia (PHR)
  • 3 Banks Worth Considering For Q4
  • Stock Market: 3 Islands Of Strength In A Sea Of Red
  • Is There a Cure for What is Ailing Teladoc Stock?
  • No One Told These 3 Stocks It's a Down Week
  • MarketBeat: Week in Review 9/12 – 9/16

Want to see what other hedge funds are holding PHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phreesia, Inc. (NYSE:PHR – Get Rating).

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment